Ferritin Nanocaged Doxorubicin Potentiates Chemo‐Immunotherapy against Hepatocellular Carcinoma via Immunogenic Cell Death
Sign Up to like & getrecommendations! Published in 2022 at "Small Methods"
DOI: 10.1002/smtd.202201086
Abstract: Although immunotherapy of hepatocellular carcinoma using immune checkpoint inhibitors has achieved certain success, only a subset of patients benefits from this therapeutic strategy. The combination of immunostimulatory chemotherapeutics represents a promising strategy to enhance the… read more here.
Keywords: immunotherapy hepatocellular; dox; hepatocellular carcinoma; dox hfn ... See more keywords
Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Immunology Research"
DOI: 10.1155/2018/9832467
Abstract: Dendritic cells (DCs) harboring tumor-associated antigen are supposed to be a potential immunotherapy for hepatocellular carcinoma (HCC). Aspartate-β-hydroxylase (AAH), an overexpressed tumor-associated cell surface protein, is considered as a promising biomarker and therapeutic target for… read more here.
Keywords: hepatocellular carcinoma; aah; aspartate hydroxylase; immunotherapy hepatocellular ... See more keywords
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359221148029
Abstract: The treatment landscape of advanced hepatocellular carcinoma (HCC) has broadened with immune checkpoint inhibitors (ICIs) setting a novel standard of care. With the increased number of therapies either in first or in further line, disentangling… read more here.
Keywords: hepatocellular carcinoma; carcinoma reshape; immunotherapy hepatocellular; icis ... See more keywords
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.589680
Abstract: Although many approaches have been used to treat hepatocellular carcinoma (HCC), the clinical benefits remain limited, particularly for late stage HCC. In recent years, studies have focused on immunotherapy for HCC. Immunotherapies have shown promising… read more here.
Keywords: hepatocellular carcinoma; carcinoma; immunotherapy hepatocellular; limits prospects ... See more keywords
Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.933210
Abstract: Necroptosis is a programmed form of necrotic cell death in regulating cancer ontogenesis, progression, and tumor microenvironment (TME) and could drive tumor-infiltrating cells to release pro-inflammatory cytokines, incurring strong immune responses. Nowadays, there are few… read more here.
Keywords: necroptosis; hepatocellular carcinoma; immunotherapy; immune infiltration ... See more keywords
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
Sign Up to like & getrecommendations! Published in 2019 at "Cancers"
DOI: 10.3390/cancers11081078
Abstract: Hepatocellular carcinoma (HCC) is the most common primary liver cancer with dismal prognosis when diagnosed at advanced stages. Surgical resection of the primary tumor or orthotropic liver transplantation serves as a potential curative option. However,… read more here.
Keywords: hepatocellular carcinoma; carcinoma; carcinoma light; immunotherapy hepatocellular ... See more keywords
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
Sign Up to like & getrecommendations! Published in 2023 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v29.i6.1054
Abstract: Hepatocellular carcinoma (HCC) is one of the world’s deadliest and fastest-growing tumors, with a poor prognosis. HCC develops in the context of chronic liver disease. Curative resection, surgery (liver transplantation), trans-arterial chemoembolization, radioembolization, radiofrequency ablation… read more here.
Keywords: hepatocellular carcinoma; carcinoma current; immunotherapy hepatocellular; future perspectives ... See more keywords
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Hepatology"
DOI: 10.4254/wjh.v14.i10.1862
Abstract: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and its incidence continues to increase. Despite improvements in both medical and surgical therapies, HCC remains associated with poor outcomes due to its… read more here.
Keywords: carcinoma promising; hepatocellular carcinoma; promising therapeutic; immunotherapy hepatocellular ... See more keywords